Anticorps Recombinant de lapin anti-ubiquitin

ubiquitin Recombinant Antibody for WB, IHC, IF/ICC, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

chien, Humain, levure, rat, souris, Hamster

Applications

WB, IHC, IF/ICC, IP, CoIP, ELISA

Conjugaison

Non conjugué

Publications(16)

CloneNo.

6H6

N° de cat : 80992-1-RR

Synonymes

UBB, ubiquitin B, 6H6, Polyubiquitin B, Polyubiquitin-B



Applications testées

Résultats positifs en WBcellules NIH/3T3, cellules NIH/3T3 traitées au MG132
Résultats positifs en IHCtissu de cancer du pancréas humain, tissu de cancer du poumon humain
il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.
Résultats positifs en IF/ICCcellules HeLa,

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:10000-1:100000
Immunohistochimie (IHC)IHC : 1:50-1:500
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

80992-1-RR cible ubiquitin dans les applications de WB, IHC, IF/ICC, IP, CoIP, ELISA et montre une réactivité avec des échantillons chien, Humain, levure, rat, souris, Hamster

Réactivité chien, Humain, levure, rat, souris, Hamster
Réactivité citéerat, Humain, souris
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène ubiquitin Protéine recombinante Ag0260
Nom complet ubiquitin B
Numéro d’acquisition GenBankBC000379
Symbole du gène ubiquitin
Identification du gène (NCBI) 7314
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS with 0.02% sodium azide and 50% glycerol
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

Ubiquitin B (UBB) is a member of ubiquitin family, one of the most conserved proteins known. Ubiquitin B is required for ATP-dependent, non-lysosomal intracellular protein degradation of abnormal proteins and normal proteins with a rapid turnover. Ubiquitin B is covalently bound to proteins to be degraded, and presumably labels these proteins for degradation. Ubiquitin also binds to histone H2A in actively transcribed regions but does not cause histone H2A degradation, suggesting that ubiquitin is also involved in regulation of gene expression.When polyubiquitin is free (unanchored-polyubiquitin), it also has distinct roles, such as in activation of protein kinases, and in signaling. This gene consists of three direct repeats of the ubiquitin coding sequence with no spacer sequence. Consequently, the protein is expressed as a polyubiquitin precursor with a final amino acid after the last repeat. Aberrant form of this protein has been noticed in patients with Alzheimer's and Down syndrome. Interestingly ubiquitin also becomes covalently bonded to many types of pathological inclusions which appear to be resistant to normal degradation.

Protocole

Product Specific Protocols
WB protocol for ubiquitin antibody 80992-1-RRDownload protocol
IHC protocol for ubiquitin antibody 80992-1-RRDownload protocol
IF protocol for ubiquitin antibody 80992-1-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Cell Signal

Repurposing a plant alkaloid homoharringtonine targets insulinoma associated-1 in N-Myc-activated neuroblastoma

Authors - Chiachen Chen
humanIP

Clin Transl Oncol

LncRNA XXYLT1-AS2 promotes tumor progression via autophagy inhibition through ubiquitinated degradation of TFEB in hepatocellular carcinoma

Authors - Xuejie Li
mouseWB,IP

Free Radic Biol Med

Carnitine functions as an enhancer of NRF2 to inhibit osteoclastogenesis via regulating macrophage polarization in osteoporosis

Authors - Tao Yang
mouseWB,IP

Biochem Pharmacol

BCL6 confers resistance to HDAC inhibitors in DLBCL

Authors - Gao Fan
humanWB

iScience

CircEZH2 promotes gallbladder cancer progression and lipid metabolism reprogramming through the miR-556-5p/SCD1 axis

Authors - Huanjun Tong
humanIP

Sci Rep

FBXO2 promotes the progression of papillary thyroid carcinoma through the p53 pathway

Authors - Wenke Guo
{{ptg:RelatedPrimaryAntibodies}}